Emami Q1FY27 profit falls 16% to ₹137cr on tax hike
Emami reported Q1FY27 revenue of ₹1,039 crore (+15% YoY) but net profit dropped 16% to ₹137 crore owing to higher tax burdens. Domestic business grew 20%, led by hair care and strategic investments, while international sales fell 12% due to geopolitical issues. Gross margins contracted by 360 bps, though management expects recovery as input costs ease.

*this image is generated using AI for illustrative purposes only.
Emami Limited reported a 16% year-on-year decline in net profit to ₹137 crore for the first quarter of FY27, despite consolidated revenue from operations rising 15% to ₹1,039 crore. The profitability contraction was primarily driven by a normalization of the effective tax rate, which surged 148% to ₹55.8 crore, eroding bottom-line gains despite resilient top-line growth anchored by domestic business. While EBITDA grew 6% to ₹226 crore, gross margins contracted by 360 basis points due to inflationary input costs and a shifting business mix toward lower-margin strategic investments.
The Board of Directors approved the unaudited financial results on August 4, 2026. Domestic business expanded by 20%, with like-to-like growth standing at 12% and volume growth at 8%. This performance was bolstered by strategic investments, including Axiom Ayurveda and IncNut Digital, which now account for 18% of domestic business and grew 61% on a like-to-like basis. Conversely, International Business declined 12% to ₹122 crore due to geopolitical disruptions in West Asia, specifically affecting OTC pain management exports from India.
Financial Performance
| Metric | Q1FY27 (₹ crore) | Q1FY26 (₹ crore) | YoY Change |
|---|---|---|---|
| Revenue from Operations | 1,039.2 | 904.1 | +15% |
| EBITDA | 226.2 | 214.2 | +6% |
| Profit Before Tax | 194.7 | 186.8 | +4% |
| Profit After Tax | 137.3 | 164.2 | -16% |
Profit Before Tax increased marginally by 4% to ₹195 crore. Management attributed the gross margin compression to higher crude oil prices and packaging costs, with approximately 200 basis points of the 360-basis-point decline linked to West Asia conflict-related supply chain issues and 160 basis points due to the integration of lower-margin startups. Rajesh Sharma, President – Finance and IR, clarified that the tax rate is expected to stabilize around 25–26% for FY27, following the expiration of fiscal benefits enjoyed in the prior year.
Segmental Breakdown
Hair & Scalp Care remained the strongest category, growing 11% to ₹271 crore, driven by double-digit growth in Navratna Cool Oil and robust performance from 7 Oils in One. Skin Care grew 3% to ₹246 crore, supported by high single-digit growth in the Talc portfolio during the summer season. Health Care expanded 2% to ₹232 crore, with the OTC portfolio delivering high teens growth. The Strategic Investments portfolio, comprising The Man Company, Brillare, Axiom Ayurveda, and IncNut Digital, showed remarkable momentum with 61% like-to-like growth.
What the Numbers Show
A critical divergence exists between operating resilience and bottom-line pressure. While EBITDA grew 6%, net profit contracted 16%, highlighting the significant impact of non-operating factors. The effective tax rate jumped from approximately 12% in Q1FY26 to nearly 29% in Q1FY27. Additionally, the company’s shift toward digital-first brands, which currently operate at EBITDA-neutral levels, is diluting overall margins in the short term. However, management projects these investments will reach high single-digit EBITDA margins within three years, suggesting current margin compression is a transitional phase rather than a structural decline.
Strategic Initiatives and Outlook
Emami is transitioning its disclosure framework from brand-wise to category-wise reporting to better reflect its diversified portfolio. The company continues its channel transformation, with organized channels growing 19% and contributing 32% of domestic business. Quick Commerce now accounts for 35% of e-commerce sales. Mohan Goenka, Vice Chairman and Whole-Time Director, expressed confidence that input cost pressures will ease and that aggressive pricing actions will offset absolute cost increases in the coming quarters. He also noted that international business disruptions are temporary, expecting significant growth recovery in Q3 and Q4 FY27 as supply chains normalize.
Historical Stock Returns for Emami
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.74% | +2.88% | -1.65% | -19.21% | -29.66% | -27.81% |
How will the projected stabilization of the effective tax rate at 25–26% impact Emami's net profit margins in subsequent quarters of FY27?
What specific strategies is Emami employing to accelerate the EBITDA margins of its digital-first strategic investments to high single-digit levels within the three-year timeline?
To what extent might the normalization of West Asian supply chains in Q3 and Q4 FY27 offset the current 12% decline in international business revenue?


































